Remove 2018 Remove Clinic Remove Individual Remove Utilities
article thumbnail

Intersections Between Gender, Race/Ethnicity and Marital Status Associations with Depression Symptoms [Behavioral, psychosocial, and mental illness]

Annals of Family Medicine

Study Design and Analysis: This study utilized survey-based methodology to estimate adjusted odds ratios (OR) and interaction effects using ordinal generalized linear model. Setting or Dataset: Data were derived from a survey dataset obtained from NHANES, specifically cross-sectional data from the 2013 to 2018 waves.

Illness 130
article thumbnail

Utility of HANDOC and CH-A in Endocarditis Triage

Physician's Weekly

They performed a population-based cohort analysis of individuals with blood cultures positive for NBHS during 2018. Medical records were reviewed to classify each episode using the HANDOC score, CH-A, and Duke-ISCVID criteria. The results showed that 325 episodes of 308 individuals with NBHS BSIs were analyzed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The utilization patterns and impact of the Stanford Chronic Pain Self-Management Program in Eastern Ontario, Canada [Pain management]

Annals of Family Medicine

Objectives: In this study, we aimed to describe patterns of utilization of a Chronic Pain Self-Management Program (CPSMP) in Eastern Ontario and evaluate the impact of the program on patient activation, a measure of participants’ involvement in their care, their health behaviors, and their knowledge of the condition.

article thumbnail

Position Statement on Measurement Based Care

Integrated Care News by CFHA

MBC is presented not simply as data collection, but as a dynamic, evidence-based clinical process that enhances outcomes, promotes equity, and strengthens team-based care. MBC supports optimal clinical practice, demonstrates the value of integrated care teams, and improves outcomes. What is MBC? 3, 4) Why is MBC important? 1, 8, 9) d.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
article thumbnail

Let’s Listen to Patients: FDA Releases Final Guidance on Patient Engagement in the Design and Conduct of Medical Device Clinical Studies

FDA Law Blog

address common questions and misconceptions about collecting and submitting to FDA patient engagement information regarding the design and conduct of a medical device clinical study.”. What would be the potential benefits if companies prospectively design medical device clinical studies with input from diverse patient advisors?

article thumbnail

The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments

FDA Law Blog

The sponsor then gets the review ball rolling by submitting all of the efficacy supplement minus the final clinical study reports and clinical summaries. based upon the anticipated clinical benefit of earlier patient access to the product.”. Notable Dates and Timelines – Applications open, Q4 of FY 2023.